Article info
PDFEditorial
Surviving hypertrophic cardiomyopathy: counting the cost of implantable cardioverter defibrillator therapy to prevent sudden death
- Correspondence to Peter A Brady, Associate Professor of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, College of Medicine, 200 First Street SW, Rochester, MN 55905, USA; brady.peter{at}mayo.edu
Citation
Surviving hypertrophic cardiomyopathy: counting the cost of implantable cardioverter defibrillator therapy to prevent sudden death
Publication history
- First published September 19, 2011.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.